Exercise intervention and inflammatory markers in coronary artery disease: A meta-analysis

American Heart Journal

Volumn 163, Issue 4, 2012, Pages

  Swardfager, Walter ^a,b   Herrmann, Nathan ^a,b   Cornish, Stephen ^a   Mazereeuw, Graham ^a,b   Marzolini, Susan ^a,b,c   Sham, Lauren ^a   Lanctôt, Krista L ^a,b,c  

^a Institute of Clinical Evaluative Sciences   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO REHABILITATION INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET THERAPY; ENERGY EXPENDITURE; EXERCISE INTENSITY; FIBRINOGEN BLOOD LEVEL; HUMAN; KINESIOTHERAPY; META ANALYSIS; PATIENT COUNSELING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING CESSATION; STRESS MANAGEMENT; SYSTEMATIC REVIEW; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84860200038     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.12.017     Document Type: Article

References (59)

1. D.A. Alter, P.I. Oh, and A. Chong Relationship between cardiac rehabilitation and survival after acute cardiac hospitalization within a universal health care system Eur J Cardiovasc Prev Rehabil 16 2009 102 113
2. G.K. Hansson, and P. Libby The immune response in atherosclerosis: a double-edged sword Nat Rev Immunol 6 2006 508 519
3. P. Libby, P.M. Ridker, and G.K. Hansson Inflammation in atherosclerosis: from pathophysiology to practice J Am Coll Cardiol 54 2009 2129 2138
4. C.A. Janeway Jr., and R. Medzhitov Innate immune recognition Annu Rev Immunol 20 2002 197 216
5. S. Stemme, B. Faber, and J. Holm T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein Proc Natl Acad Sci U S A 92 1995 3893 3897
6. J. Frostegard, A.K. Ulfgren, and P. Nyberg Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines Atherosclerosis 145 1999 33 43
7. M. Pynn, K. Schafer, and S. Konstantinides Exercise training reduces neointimal growth and stabilizes vascular lesions developing after injury in apolipoprotein e-deficient mice Circulation 109 2004 386 392
8. K. Fukao, K. Shimada, and H. Naito Voluntary exercise ameliorates the progression of atherosclerotic lesion formation via anti-inflammatory effects in apolipoprotein E-deficient mice J Atheroscler Thromb 17 2010 1226 1236
9. A. Niessner, B. Richter, and M. Penka Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque stabilization? Atherosclerosis 186 2006 160 165
10. S. Kaptoge, E. Di Angelantonio, and G. Lowe C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Lancet 375 2010 132 140
11. P.M. Ridker, N.P. Paynter, and N. Rifai C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men Circulation 118 2008 2243 2251 [4p following 2251]
12. M. Benderly, E. Graff, and H. Reicher-Reiss Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) study group Arterioscler Thromb Vasc Biol 16 1996 351 356
13. J. Danesh, S. Lewington, and S.G. Thompson Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis JAMA 294 2005 1799 1809
14. S. Blankenberg, H.J. Rupprecht, and C. Bickel Circulating cell adhesion molecules and death in patients with coronary artery disease Circulation 104 2001 1336 1342
15. E. Lindmark, E. Diderholm, and L. Wallentin Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy JAMA 286 2001 2107 2113
16. H. Bruunsgaard, P. Skinhoj, and A.N. Pedersen Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis Clin Exp Immunol 121 2000 255 260
17. R.M. Oemrawsingh, T. Lenderink, and K.M. Akkerhuis Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome Heart 97 2011 1061 1066
18. C. Kasapis, and P.D. Thompson The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review J Am Coll Cardiol 45 2005 1563 1569
19. G.A. Kelley, and K.S. Kelley Effects of aerobic exercise on C-reactive protein, body composition, and maximum oxygen consumption in adults: a meta-analysis of randomized controlled trials Metabolism 55 2006 1500 1507
20. C.J. Lavie, T.S. Church, and R.V. Milani Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation J Cardiopulm Rehabil Prev 31 2011 137 145
21. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration PLoS Med 6 2009 e1000100
22. S. Kodama, S. Tanaka, and K. Saito Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis Arch Intern Med 167 2007 999 1008
23. R.J. Harris, M.J. Bradburn, and J.J. Deeks Metan: fixed- and random-effects meta-analysis Stata J 8 2008 3 28
24. J.E. Noble, L. Wang, and E. Cerasoli An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISA Clin Chem Lab Med 46 2008 1033 1045
25. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
26. M. Egger, G. Davey Smith, and M. Schneider Bias in meta-analysis detected by a simple, graphical test Bmj 315 1997 629 634
27. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
28. P.A. Ades, P.D. Savage, and M.J. Toth High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients Circulation 119 2009 2671 2678
29. S. Balen, N. Vukelic-Damijani, and V. Persic Anti-inflammatory effects of exercise training in the early period after myocardial infarction Coll Antropol 32 2008 285 291
30. T.M. Beckie, J.W. Beckstead, and M.W. Groer The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease J Cardiovasc Nurs 25 2010 52 60
31. T. Caulin-Glaser, J. Falko, and L. Hindman Cardiac rehabilitation is associated with an improvement in C-reactive protein levels in both men and women with cardiovascular disease J Cardiopulm Rehabil 25 2005 332 336 [quiz 337-8]
32. V.M. Conraads, P. Beckers, and J. Bosmans Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease Eur Heart J 23 2002 1854 1860
33. H.S. Dod, R. Bhardwaj, and V. Sajja Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis Am J Cardiol 105 2010 362 367
34. J. Lara Fernandes, C.V. Serrano Jr., and F. Toledo Acute and chronic effects of exercise on inflammatory markers and B-type natriuretic peptide in patients with coronary artery disease Clin Res Cardiol 100 2011 77 84
35. E. Goldhammer, A. Tanchilevitch, and I. Maor Exercise training modulates cytokines activity in coronary heart disease patients Int J Cardiol 100 2005 93 99
36. D. Hansen, P. Dendale, and J. Berger Importance of exercise training session duration in the rehabilitation of coronary artery disease patients Eur J Cardiovasc Prev Rehabil 15 2008 453 459
37. Y.J. Kim, Y.O. Shin, and J.S. Bae Beneficial effects of cardiac rehabilitation and exercise after percutaneous coronary intervention on hsCRP and inflammatory cytokines in CAD patients Pflugers Arch 455 2008 1081 1088
38. C.J. Lavie, R.V. Milani, and S.M. Artham The obesity paradox, weight loss, and coronary disease Am J Med 122 2009 1106 1114
39. T.H. Luk, Y.L. Dai, and C.W. Siu Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial Eur J Cardiovasc Prev Rehabil 2011
40. R.V. Milani, C.J. Lavie, and M.R. Mehra Reduction in C-reactive protein through cardiac rehabilitation and exercise training J Am Coll Cardiol 43 2004 1056 1061
41. T. Onishi, K. Shimada, and S. Sunayama Effects of cardiac rehabilitation in patients with metabolic syndrome after coronary artery bypass grafting J Cardiol 53 2009 381 387
42. C.E. Pluss, M.R. Karlsson, and N.H. Wallen Effects of an expanded cardiac rehabilitation programme in patients treated for an acute myocardial infarction or a coronary artery by-pass graft operation Clin Rehabil 22 2008 306 318
43. G. Rankovic, B. Milicic, and T. Savic Effects of physical exercise on inflammatory parameters and risk for repeated acute coronary syndrome in patients with ischemic heart disease Vojnosanit Pregl 66 2009 44 48
44. A. Schumacher, K. Peersen, and L. Sommervoll Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease Eur J Cardiovasc Prev Rehabil 13 2006 356 362
45. Y.O. Shin, J.S. Bae, and J.B. Lee Effect of cardiac rehabilitation and statin treatment on anti-HSP antibody titers in patients with coronary artery disease after percutaneous coronary intervention Int Heart J 47 2006 671 682
46. S. Sixt, A. Rastan, and S. Desch Exercise training but not rosiglitazone improves endothelial function in prediabetic patients with coronary disease Eur J Cardiovasc Prev Rehabil 15 2008 473 478
47. S. Sixt, S. Beer, and M. Bluher Long- but not short-term multifactorial intervention with focus on exercise training improves coronary endothelial dysfunction in diabetes mellitus type 2 and coronary artery disease Eur Heart J 31 2010 112 119
48. T. Suzuki, K. Yamauchi, and Y. Yamada Blood coagulability and fibrinolytic activity before and after physical training during the recovery phase of acute myocardial infarction Clin Cardiol 15 1992 358 364
49. C. Walther, S. Mobius-Winkler, and A. Linke Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease Eur J Cardiovasc Prev Rehabil 15 2008 107 112
50. D. Wosornu, W. Allardyce, and D. Ballantyne Influence of power and aerobic exercise training on haemostatic factors after coronary artery surgery Br Heart J 68 1992 181 186
51. M.I. Cybulsky, and M.A. Gimbrone Jr Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science 251 1991 788 791
52. C. Wadham, N. Albanese, and J. Roberts High-density lipoproteins neutralize C-reactive protein proinflammatory activity Circulation 109 2004 2116 2122
53. G.A. Kelley, K.S. Kelley, and S. Roberts Efficacy of aerobic exercise and a prudent diet for improving selected lipids and lipoproteins in adults: a Meta-Analysis of Randomized Controlled Trials BMC Med 9 2011 74
54. L. Gullestad, and P. Aukrust Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches Am J Cardiol 95 2005 17C 23C [discussion 38C-40C]
55. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 150 2009 396 404
56. D.A. Morrow, J.A. de Lemos, and M.S. Sabatine Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial Circulation 114 2006 281 288
57. Y. Zhao, X. He, and C. Huang The impacts of thiazolidinediones on circulating C-reactive protein levels in different diseases: a meta-analysis Diabetes Res Clin Pract 90 2010 279 287
58. T.D. Wang, W.J. Chen, and W.C. Cheng Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome Am J Cardiol 98 2006 1057 1062
59. Medicine ACoS American College of Sports Medicine's guidelines for exercise testing and prescription 2009 Lippincott Williams and Wilkins Philadelphia